Literature DB >> 24265997

Treatment of a lateral tibial plateau osteochondritis dissecans lesion with subchondral injection of calcium phosphate.

Geoffrey D Abrams1, Eduard Alentorn-Geli, Joshua D Harris, Brian J Cole.   

Abstract

Osteochondritis dissecans lesions occur frequently in children and adolescents. Treatment can be challenging and depends on the status of the articular cartilage and subchondral bone. Injection of calcium phosphate bone substitute into the area of subchondral bone edema (Subchondroplasty; Knee Creations, West Chester, PA) may be an option. We present a case of a lateral tibial plateau osteochondritis dissecans lesion treated with subchondral injection of nanocrystalline calcium phosphate. Preoperative magnetic resonance imaging is used to determine the area of subchondral edema, and intraoperative fluoroscopy is used to localize this area with the injection cannula. Calcium phosphate is injected by use of a series of syringes until the appropriate fill is obtained. Treatment of concomitant cartilage defects may also be carried out at this time.

Entities:  

Year:  2013        PMID: 24265997      PMCID: PMC3834648          DOI: 10.1016/j.eats.2013.03.001

Source DB:  PubMed          Journal:  Arthrosc Tech        ISSN: 2212-6287


  20 in total

1.  Characteristic shape of the lateral femoral condyle in patients with osteochondritis dissecans accompanied by a discoid lateral meniscus.

Authors:  Goki Kamei; Nobuo Adachi; Masataka Deie; Atsuo Nakamae; Tomoyuki Nakasa; Hayatoshi Shibuya; Atsushi Okuhara; Takuya Niimoto; Hiromi Kazusa; Shingo Ohkawa; Kobun Takazawa; Akio Eguchi; Mitsuo Ochi
Journal:  J Orthop Sci       Date:  2012-01-06       Impact factor: 1.601

Review 2.  Management of osteochondritis dissecans of the knee: current concepts review.

Authors:  Mininder S Kocher; Rachael Tucker; Theodore J Ganley; John M Flynn
Journal:  Am J Sports Med       Date:  2006-07       Impact factor: 6.202

3.  Effectiveness and limitations of autologous osteochondral grafting for the treatment of articular cartilage defects in the knee.

Authors:  Shinji Imade; Nobuyuki Kumahashi; Suguru Kuwata; Jyunji Iwasa; Yuji Uchio
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-07-12       Impact factor: 4.342

4.  Outcomes of autologous chondrocyte implantation in study of the treatment of articular repair (STAR) patients with osteochondritis dissecans.

Authors:  Brian J Cole; Thomas DeBerardino; Robert Brewster; Jack Farr; David W Levine; Carl Nissen; Prudence Roaf; Kenneth Zaslav
Journal:  Am J Sports Med       Date:  2012-07-19       Impact factor: 6.202

5.  Can fresh osteochondral allografts restore function in juveniles with osteochondritis dissecans of the knee?

Authors:  Roger Lyon; Carl Nissen; Xue Cheng Liu; Brian Curtin
Journal:  Clin Orthop Relat Res       Date:  2013-04       Impact factor: 4.176

6.  Juvenile osteochondritis dissecans of the knee: predictors of lesion stability.

Authors:  Walter P Samora; Julie Chevillet; Brent Adler; Gregory S Young; Kevin E Klingele
Journal:  J Pediatr Orthop       Date:  2012 Jan-Feb       Impact factor: 2.324

7.  Osteochondritis dissecans: a multicenter study of the European Pediatric Orthopedic Society.

Authors:  F Hefti; J Beguiristain; R Krauspe; B Möller-Madsen; V Riccio; C Tschauner; R Wetzel; R Zeller
Journal:  J Pediatr Orthop B       Date:  1999-10       Impact factor: 1.041

8.  Long-term results of arthroscopic excision of unstable osteochondral lesions of the lateral femoral condyle.

Authors:  H-C Lim; J-H Bae; Y-E Park; Y-H Park; J-H Park; J-W Park; D-H Suh
Journal:  J Bone Joint Surg Br       Date:  2012-02

9.  The healing potential of stable juvenile osteochondritis dissecans knee lesions.

Authors:  Eric J Wall; Jason Vourazeris; Gregory D Myer; Kathleen H Emery; Jon G Divine; Todd G Nick; Timothy E Hewett
Journal:  J Bone Joint Surg Am       Date:  2008-12       Impact factor: 5.284

Review 10.  Evaluation and treatment of osteochondritis dissecans lesions of the knee.

Authors:  Alvin J Detterline; Jordan L Goldstein; John-Paul H Rue; Bernard R Bach
Journal:  J Knee Surg       Date:  2008-04       Impact factor: 2.757

View more
  7 in total

Review 1.  Evaluation and Management of Subchondral Calcium Phosphate Injection Technique to Treat Bone Marrow Lesion.

Authors:  Diego Costa Astur; Eduardo Vasconcelos de Freitas; Pedro Barreira Cabral; Caio Carvalho Morais; Bruno Silveira Pavei; Camila Cohen Kaleka; Pedro Debieux; Moises Cohen
Journal:  Cartilage       Date:  2018-04-18       Impact factor: 4.634

2.  Subchondral Calcium Phosphate is Ineffective for Bone Marrow Edema Lesions in Adults With Advanced Osteoarthritis.

Authors:  Dipal Chatterjee; Alan McGee; Eric Strauss; Thomas Youm; Laith Jazrawi
Journal:  Clin Orthop Relat Res       Date:  2015-04-28       Impact factor: 4.176

Review 3.  Surgical modalities for the management of bone marrow edema of the knee joint.

Authors:  Athanasios N Ververidis; Konstantinos Paraskevopoulos; Konstantinos Tilkeridis; Georgios Riziotis; Stylianos Tottas; Georgios I Drosos
Journal:  J Orthop       Date:  2019-08-15

4.  Management of Bone Marrow Lesions of the Hip With Subchondral Calcium Phosphate Injection: Surgical Technique and Tips.

Authors:  Nikhil Kapil; Linsen T Samuel; Atul F Kamath
Journal:  Arthrosc Tech       Date:  2020-06-13

5.  The Efficacy of Subchondroplasty for the Treatment of Knee Pain Associated with Bone Marrow Lesions.

Authors:  Nathan M Krebs; James L Kehoe; Michael J Van Wagner; Carlos Rios-Bedoya
Journal:  Spartan Med Res J       Date:  2020-01-30

6.  Hitting the Mark: Optimizing the Use of Calcium Phosphate Injections for the Treatment of Bone Marrow Lesions of the Proximal Tibia and Distal Femur.

Authors:  Brian J Rebolledo; Kevin M Smith; Jason L Dragoo
Journal:  Arthrosc Tech       Date:  2018-09-10

7.  Osteochondritis Dissecans of the Tibial Plateau in Children and Adolescents: A Case Series.

Authors:  Millicent Croman; Dennis E Kramer; Benton E Heyworth; Mininder S Kocher; Lyle J Micheli; Yi-Meng Yen
Journal:  Orthop J Sports Med       Date:  2020-08-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.